Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 7, 2024Cancer InnovationOpen Access

Histone deacetylase 6 as a novel promising target to treat cardiovascular disease

View Full Paper
Ask AI
Bookmark
Share

Authors

YWYa‐Xi WuZhengzhou UniversityBLBing‐Qian LiSouthwest UniversityXYXiaoqian YuKing University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wu et al. (2024) studied this question.

synapsesocial.com/papers/68e6b299b6db643587633fbchttps://doi.org/10.1002/cai2.114
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Suppression of Class I and II Histone Deacetylases Blunts Pressure-Overload Cardiac Hypertrophy2006 · 378 citations
  2. 2Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies2021 · 136 citations
  3. 3Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis2019 · 82 citations
  4. 4Honokiol ameliorates angiotensin II‐induced hypertension and endothelial dysfunction by inhibiting HDAC6‐mediated cystathionine γ‐lyase degradation2020 · 33 citations